Literature DB >> 12075171

Ubiquitin proteasome inhibition and cancer therapy.

Shimul A Shah1, Michael W Potter, Mark P Callery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075171     DOI: 10.1067/msy.2002.121890

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  2 in total

1.  Simplified synthetic TMC-95A/B analogues retain the potency of proteasome inhibitory activity.

Authors:  Zhi-Qiang Yang; Benjamin H B Kwok; Songnian Lin; Michael A Koldobskiy; Craig M Crews; Samuel J Danishefsky
Journal:  Chembiochem       Date:  2003-06-06       Impact factor: 3.164

2.  Proteasome Inhibitor YSY01A Abrogates Constitutive STAT3 Signaling via Down-regulation of Gp130 and JAK2 in Human A549 Lung Cancer Cells.

Authors:  Wei Huang; Xia Yuan; Ting Sun; Shujie Fan; Jun Wang; Quan Zhou; Wei Guo; Fuxiang Ran; Zemei Ge; Huayu Yang; Runtao Li; Jingrong Cui
Journal:  Front Pharmacol       Date:  2017-08-24       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.